157 related articles for article (PubMed ID: 30559936)
1. Correction: Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
[TBL] [Abstract][Full Text] [Related]
2. Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2017 Sep; 8(40):67871-67877. PubMed ID: 28978080
[TBL] [Abstract][Full Text] [Related]
3. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
4. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
[TBL] [Abstract][Full Text] [Related]
5. Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.
Kakar SS; Parte S; Carter K; Joshua IG; Worth C; Rameshwar P; Ratajczak MZ
Oncotarget; 2020 Aug; 11(32):3103-3104. PubMed ID: 32850014
[TBL] [Abstract][Full Text] [Related]
6. Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.
Kang MH; Jeong GS; Smoot DT; Ashktorab H; Hwang CM; Kim BS; Kim HS; Park YY
Oncotarget; 2018 Dec; 9(98):37268. PubMed ID: 30647858
[TBL] [Abstract][Full Text] [Related]
7. Correction: A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
Oncotarget; 2017 Aug; 8(34):57905. PubMed ID: 28915722
[TBL] [Abstract][Full Text] [Related]
8. Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression.
Hu MH; Ma CY; Wang XM; Ye CD; Zhang GX; Chen L; Wang JG
Oncotarget; 2021 Aug; 12(18):1859-1860. PubMed ID: 34504658
[TBL] [Abstract][Full Text] [Related]
9. Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.
Guan B; Wu K; Zeng J; Xu S; Mu L; Gao Y; Wang K; Ma Z; Tian J; Shi Q; Guo P; Wang X; He D; Du Y
Oncotarget; 2022; 13():507. PubMed ID: 35284038
[TBL] [Abstract][Full Text] [Related]
10. Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
Li S; Zhu Y; Liang Z; Wang X; Meng S; Xu X; Xu X; Wu J; Ji A; Hu Z; Lin Y; Chen H; Mao Y; Wang W; Zheng X; Liu B; Xie L
Oncotarget; 2019 Jan; 10(6):684. PubMed ID: 30774765
[TBL] [Abstract][Full Text] [Related]
11. Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
Oncotarget; 2018 Aug; 9(60):31787. PubMed ID: 30167094
[TBL] [Abstract][Full Text] [Related]
12. Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity.
Jiang Y; Ma Y; Li R; Sun J
Oncotarget; 2018 Aug; 9(60):31788. PubMed ID: 30167095
[TBL] [Abstract][Full Text] [Related]
13. Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
Qiu W; Yang Z; Fan Y; Zheng Q
Oncotarget; 2022; 13():614. PubMed ID: 35419172
[TBL] [Abstract][Full Text] [Related]
14. Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
Hou T; Zhou L; Wang L; Kazobinka G; Zhang X; Chen Z
Oncotarget; 2019 Jan; 10(9):1010. PubMed ID: 30847028
[TBL] [Abstract][Full Text] [Related]
15. Correction: Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
Oncotarget; 2020 Jan; 11(3):302-303. PubMed ID: 32076491
[TBL] [Abstract][Full Text] [Related]
16. Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
Ziouziou H; Andrieu C; Laurini E; Karaki S; Fermeglia M; Oueslati R; Taieb D; Camplo M; Siri O; Pricl S; Katsogiannou M; Rocchi P
Oncotarget; 2018 Jun; 9(47):28797. PubMed ID: 29983898
[TBL] [Abstract][Full Text] [Related]
17. Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.
Reeves PM; Abbaslou MA; Kools FRW; Vutipongsatorn K; Tong X; Gavegnano C; Schinazi RF; Poznansky MC
Oncotarget; 2018 Jul; 9(54):30472. PubMed ID: 30101001
[TBL] [Abstract][Full Text] [Related]
18. Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
Oncotarget; 2022; 13():684-685. PubMed ID: 35574219
[TBL] [Abstract][Full Text] [Related]
19. Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models.
Feldman T; Grossman-Haham I; Elkis Y; Vilela P; Moskovits N; Barshack I; Salame TM; Fass D; Ilani T
Oncotarget; 2020 Oct; 11(40):3687. PubMed ID: 33088428
[TBL] [Abstract][Full Text] [Related]
20. Correction: Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.
Zhang Y; Qu X; Teng Y; Li Z; Xu L; Liu J; Ma Y; Fan Y; Li C; Liu S; Wang Z; Hu X; Zhang J; Liu Y
Oncotarget; 2021 Aug; 12(16):1634-1637. PubMed ID: 34381570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
